FDAnews
www.fdanews.com/articles/209753-gestalt-diagnostics-gains-two-ce-ivd-marks

Gestalt Diagnostics Gains Two CE-IVD Marks

October 12, 2022

Spokane, Wash.-based Gestalt Diagnostics has received CE-IVD marks for two main components of its PathFlow product, which digitizes laboratory slides, makes them viewable and automates the images into a pathology laboratory workflow.

PathFlow is a cloud-based digital pathology platform that can be customized with education and research modules to suit a facility’s needs.

The platform is designed to use every component necessary to streamline the workflow for pathologists in clinical, education and research laboratories, as well as healthcare facilities, the company said.

View today's stories